New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
16:19 EDTMCKMcKesson falls after earnings and guidance, first look
The shares were last down over 4.7% in the extended session following the company's earnings release and guidance. At the current price of $100.24, next support is at $99.88, the 10-week moving average. A break below this level would snap the uptrend in place since September of last year. Next support would then be at $96.08, a prior pivot high.
News For MCK From The Last 14 Days
Check below for free stories on MCK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
07:33 EDTMCKMcKesson raises FY15 adjusted EPS view to $10.50-$10.90 from $10.40-$10.80
Subscribe for More Information
07:32 EDTMCKMcKesson reports Q1 adjusted continuing ops EPS $2.49, consensus $2.33
Subscribe for More Information
July 30, 2014
15:40 EDTMCKNotable companies reporting before tomorrow's open
Subscribe for More Information
09:47 EDTMCKLeerink healthcare analyst holds an analyst/industry conference call
Subscribe for More Information
09:00 EDTMCKMcKesson extends pharmaceutical distribution agreement with CVS Caremark
McKesson Corporation (MCK) announced a three-year extension of its existing distribution agreement with CVS Caremark (CVS) through June, 2019. “We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” said Paul Julian, executive vice president, group president, McKesson Corporation. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
July 28, 2014
07:26 EDTMCKAmerican Association for Clinical Chemistry to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use